Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2015
Corbalan F., Beaulieu S., Armony J. (2015). Emotion regulation in bipolar disorder type I: an fMRI study, Psychol Med, 45(12), 2521-31. Find out more.
Parikh S. V., Hawke L. D., Velyvis V., Zaretsky A., Beaulieu S., Patelis-Siotis I., MacQueen G., Young L. T., Yatham L. N., Cervantes P. (2015). Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder, Bipolar Disord, 17(1), 86-96. Find out more.
Yatham L. N., Beaulieu S., Schaffer A., Kauer-Sant'Anna M., Kapczinski F., Lafer B., Sharma V., Parikh S. V., Daigneault A., Qian H., Bond D. J., Silverstone P. H., Walji N., Milev R., Baruch P., da Cunha A., Quevedo J., Dias R., Kunz M., Young L. T., Lam R. W., Wong H. (2015). Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial, Mol Psychiatry. Find out more.